Biden was inaugurated on January 20, 2021, and within 24 hours the signal was out. All Section 301 tariffs on Chinese goods would stay. Not temporarily. Not pending a quick look. Pending a “comprehensive strategic assessment” with no published timeline, no milestones, no end date. If you spent any part of late 2020 quietly assuming that a change in administration would bring tariff relief on your China chemical imports by mid-2021, that assumption died on Day 1. Plan for these tariffs to be permanent.
“Strategic patience” is the phrase Biden’s trade team used. It is a polite way of saying your pain continues until we decide otherwise, and we have not decided. Here is what that actually meant for procurement teams, what Katherine Tai’s nomination told you, where the four tariff lists stood, and what cost-reduction tools you could still use inside the existing framework.
What “Strategic Patience” Actually Meant in Procurement Terms
The incoming Biden administration was consistent and deliberate from day one. Senior officials made clear in January 2021 that they viewed the Section 301 tariffs as a negotiating instrument for future engagement with Beijing, not as a policy error inherited from Trump. Removing them unilaterally before negotiations would hand away one of the few concrete pieces of leverage the US held in any future trade framework discussion. That rationale was stated plainly.
For importers, this had a direct operational meaning. There was no near-term trigger that would cause tariff rates to fall. Not an early executive order, not a preliminary review finding, not a bilateral summit. The tariff schedule on January 20, 2021 was the tariff schedule you needed to model for all of 2021 and very likely 2022 as well. Companies that had built cost projections in late 2020 using a “maybe tariffs drop by mid-2021” scenario needed to revise those projections on January 21st.
Katherine Tai’s 98-0 Confirmation Vote Told You Everything
Katherine Tai was nominated as US Trade Representative, and her early 2021 confirmation hearings were the clearest window into how the Biden administration intended to frame China trade policy for the next four years.
Tai’s stated philosophy was “worker-centred trade policy,” a formulation that prioritised outcomes for US manufacturing workers over trade-flow efficiency or consumer cost minimisation. In practical terms, that framing was directly hostile to the case for tariff reduction. The standard importer argument against Section 301, that it functions as a tax on US buyers and consumers, was precisely the argument a worker-centred framework was designed to override.
Tai said explicitly that she would not remove tariffs before a strategic review was complete. Then the Senate confirmed her 98 to 0. Not 60 to 40. Ninety-eight to zero. That is a bipartisan signal that her approach had support across the entire political spectrum. Importers who read Biden’s more multilateral rhetoric as a hint that China tariffs were softening misread the situation entirely. The 98-0 vote was the correct read.
For chemical importers specifically, the worker-centred framing meant USTR under Tai would be unsympathetic to industry arguments that tariffs on chemical raw materials were harming US competitiveness. Those arguments were heard. They were not going to move the policy needle in 2021.
The Four Tariff Lists: What Is Still Hitting Your Products
Understanding the actual structure that remained in place is essential for modelling landed costs accurately. Many importers were still confused about which list applied to their specific products in early 2021, and that confusion was costing them money.
| Tariff List | Annual Trade Value | Rate | Key Chemical Coverage |
|---|---|---|---|
| List 1 | ~$34 billion | 25% | Certain organic chemicals, resins, HTS Chapters 28–29 intermediates |
| List 2 | ~$16 billion | 25% | Inorganic chemicals, certain semiconductor-related compounds |
| List 3 | ~$200 billion | 25% | Specialty chemicals, adhesives, coatings, plasticisers, commodity organics and solvents |
| List 4A | ~$120 billion | 7.5% | Selected consumer goods and some specialty chemical categories |
Total annual Section 301 tariff payments on chemical imports from China were running at $500 to $600 million across the US chemical importing community per year. Those payments continued without interruption on January 21, 2021, exactly as they had on January 19.
The USTR exclusion process remained open. Individual companies could petition for product-specific exclusions, and the Biden administration continued processing those requests. But no expansion of the exclusion programme was announced in January 2021, and exclusion approvals remained narrow and case-specific. If your product had not already received an exclusion, the probability of getting one in 2021 without a dedicated legal and regulatory effort was low.
Modelling Section 301 as a Permanent Cost Changes Everything
When tariffs are expected to be temporary, the rational approach is to keep contract terms short, avoid locking tariff costs into long-term pricing agreements, and maintain flexibility to reprice quickly when rates change. That was a reasonable approach in 2018 and early 2019, when the tariff schedule was actively changing. It was not rational by January 2021.
Twenty months of tariff stability, combined with clear Day 1 Biden signals, was sufficient evidence that the rates were structurally embedded. The correct response was to incorporate Section 301 costs into your baseline cost of goods calculation and to negotiate supplier pricing with that baseline baked in, rather than treating it as a separate pass-through line that might disappear. If you had been absorbing tariff costs out of margin while waiting for relief, and your supplier price did not reflect those costs, you were effectively subsidising your own supply chain. Renegotiating to incorporate a tariff-adjusted cost basis was uncomfortable. It was also the accurate reflection of economic reality.
Three Underused Cost-Reduction Tools That Were Still Available
The tariff rates were fixed. That did not mean your effective tariff burden was fixed. Three tools were significantly underused by US chemical importers in 2021.
Foreign Trade Zones offered the most significant potential relief for importers with US manufacturing operations. Goods entering an FTZ are not subject to tariff payment until they leave for US consumption. That creates a real cash flow benefit and, for companies that exported finished products, the potential to eliminate tariffs on Chinese inputs that ended up in exported goods. Setting up FTZ operations required regulatory work and physical logistics reorganisation, but for importers paying more than $2 million per year in Section 301 duties, the economics were compelling.
| Annual Section 301 Duty Spend | FTZ Worth Investigating? | Estimated Annual Saving Potential |
|---|---|---|
| Under $500,000 | Probably not, setup cost too high relative to benefit | Minimal |
| $500,000 to $2 million | Possibly, depends on export proportion of finished goods | $50,000 to $400,000 |
| Over $2 million | Yes, serious conversation warranted immediately | $200,000 to $1 million+ |
First-sale valuation is a customs law provision that allows tariffs to be assessed on the price paid by the first buyer in a multi-party transaction, rather than the final export price. In a supply chain where a Chinese manufacturer sells to a trading company that then sells to a US importer, the factory-to-trader price is typically lower than the trader-to-importer price. Tariffs assessed on the first-sale price can reduce the dutiable value meaningfully. It requires documentary evidence and specific customs filings, but it is available, it is legal, and it is genuinely underused. If your China supply chain runs through a trader, talk to your customs broker about first-sale eligibility this week.
HTS code reclassification review was worth undertaking for any importer who had not had a customs attorney look at their classifications in the prior 12 months. Misclassifications happen in both directions: products placed on a higher-tariff list that have a defensible alternative classification on a lower-tariff list, and products incorrectly excluded from tariff coverage. A systematic review of your top 10 imported chemical products by value often uncovered at least one reclassification opportunity that reduced total tariff exposure. The cost of the review is almost always worth it.
Biden vs. Trump: Same Rates, Very Different Risk Profile
The tariff schedule under Biden in January 2021 looked identical to the tariff schedule under Trump on January 19, 2021. Same rates, same lists, same USTR exclusion process. From a landed cost perspective, nothing changed at the border on January 20.
The difference was in trajectory. The Trump administration used tariffs as direct economic coercion, explicitly tied to specific short-term negotiating demands, with rates that could move up or down on short notice following a tweet or a bilateral meeting. That made the environment volatile but also created real possibilities for rapid rate changes when political deals were struck, as happened with List 4A under Phase One. The Biden administration framed tariffs as one instrument within a broader multilateral trade strategy. That framing, while more coherent as long-term strategy, meant the tariff environment was going to change slowly if at all. There were no short-term deal triggers on the horizon in either direction.
For chemical import tariffs in 2021, the Biden framing was actually more stable and more predictable than the Trump environment had been, even though the rates were identical. Importers knew rates were unlikely to spike upward on short notice. They also knew rates were not going to drop. Both directions of volatility were reduced.
Build your supplier pricing, freight assumptions, and duty costs into a three-year landed cost model. Update it quarterly. Stop waiting for relief that is not coming on any near-term timeline. The companies that made that adjustment in January 2021 made better sourcing decisions throughout the year than those who kept holding out for a USTR announcement that never came.